Abigail Shrier argues that a sudden epidemic of transgender identification among Western adolescent girls represents not traditional gender dysphoria but a social contagion, akin to historical waves of anorexia and cutting, spread through social media, peer groups, schools, and an activist-driven medical establishment. Gender dysphoria historically afflicted roughly .01 percent of the population, almost exclusively boys, with onset in early childhood. Before 2012, no scientific literature documented adolescent girls developing it, yet in the last decade the sex ratio flipped to majority adolescent girls. Drawing on nearly 200 interviews with clinicians, parents, transgender adults, and detransitioners (those who transitioned and later reversed course), Shrier contends that vulnerable teenage girls are being ushered toward irreversible medical interventions by a culture that has abandoned parental authority and professional skepticism.
Shrier opens with "Lucy," whose mother describes a feminine child who loved Disney princesses and dated boys through high school. Lucy had anxiety, depression, and a bipolar II diagnosis, and her older sister's addiction consumed her parents' attention. At a liberal arts college, she was invited to state her gender pronouns; when her anxiety flared, she and several friends concluded their distress was gender dysphoria. Within a year, Lucy began testosterone, shaved her head, and was considering top surgery, a voluntary double mastectomy. Shrier distinguishes Lucy from transgender adults who describe lifelong discomfort in their bodies and typically knew no other trans people growing up.
Shrier argues that today's adolescent girls are uniquely vulnerable, citing steep rises in self-harm and depression since 2009 driven by social media and smartphones. She profiles families whose daughters discovered transgender identity through the internet or school peer groups, pursued medical transition, and cut off skeptical parents. "Julie," a ballet dancer raised by two mothers in the Midwest, joined her school's Gay-Straight Alliance, began testosterone after graduating, underwent a double mastectomy, and cut off contact with her mothers. "Sally," a champion swimmer on an Ivy League athletic scholarship, came out as a lesbian in college; after a devastating breakup, a campus counselor suggested she might be transgender. After her father suggested she tone down her appearance for job interviews, Sally declared her parents "toxic" and severed contact. "Gayatri," a daughter of Indian immigrants, discovered transgender communities on Tumblr and DeviantArt after getting a smartphone and announced a transgender identity.
Shrier presents the research of Lisa Littman, a public health researcher who in 2016 noticed several adolescents in her Rhode Island town coming out as transgender within the same friend group. Littman surveyed 256 parents and found that 65 percent of the adolescents adopted a transgender identity after prolonged social media use, with prevalence in some friend groups exceeding expected rates more than 70 times. She coined the term "rapid-onset gender dysphoria" (ROGD), hypothesizing that contagious beliefs drove the phenomenon: that nonspecific symptoms prove one is transgender, that transition is the only cure, and that dissenters are transphobic. Activists attacked the paper and Littman lost a paid consultancy; a correction issued months later changed none of her results.
Shrier examines transgender social media influencers who assure adolescents they are probably trans, portray testosterone as harmless, urge them to cut off skeptical parents, and coach them to deceive therapists. Influencers define dysphoria so broadly that nearly any teenager could qualify. Shrier reports that California's mandatory gender identity instruction bars parental opt-out, with the ACLU, Planned Parenthood, and GLSEN supplying curricula. The California Teachers Association voted to allow trans-identified minor students to leave campus to obtain cross-sex hormones without parental permission.
Shrier profiles parents who found themselves sidelined. Katherine Cave, a progressive lawyer, consulted ten therapists after her twelve-year-old announced a transgender identity following a school assembly; all said children this age know who they are. A gender clinic warned of suicide risk without affirmation. Cave acquiesced to pronoun changes but, upon learning that nearly all children on puberty blockers proceed to cross-sex hormones, refused further intervention. After learning the school had used a male name without her knowledge, she founded the Kelsey Coalition. Brie Jontry quit her job and moved across the country to separate her daughter from the reinforcing peer group; her daughter stopped identifying as transgender.
Shrier critiques "affirmative care," endorsed by the American Medical Association, American Psychological Association, and American Academy of Pediatrics, which mandates that therapists accept patients' self-diagnosed gender identities. She challenges its premises: The prefrontal cortex does not fully develop until age 25, making teenagers neurologically prone to risky, peer-approved behavior. Social transition may harden an identity and make reversal painful. The commonly cited 41 percent suicide attempt rate has methodological flaws, and no evidence shows affirmation reduces suicidality. Studies indicate nearly 70 percent of children with gender dysphoria who are not affirmed outgrow it.
Shrier profiles dissenting clinicians. Kenneth Zucker, who oversaw the definition of "gender dysphoria" for the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), practiced therapy helping patients become comfortable in their bodies; his colleague found that 88 percent of boys not socially transitioned outgrew their dysphoria. In 2015, activists had Zucker fired and his clinic shut down. Jungian analyst Lisa Marchiano argues gender dysphoria has entered the cultural "symptom pool," a recognized way of expressing distress. Johns Hopkins psychiatrist Paul McHugh predicts the phenomenon will end in the courts, with patients suing their doctors.
Shrier argues that cultural shifts have elevated transgender identity while devaluing womanhood. On progressive campuses, trans identification offers white, upper-middle-class girls escape from a reviled identity category. She profiles "Meredith," who had a mental health crisis at an Ivy League school; after a classmate suggested she might be transgender, Meredith began testosterone distributed by her university on an informed-consent basis.
Shrier details the medical interventions. Lupron, a puberty blocker originally used in chemical castration of sex offenders, is prescribed off-label to gender dysphoric minors; in clinical trials, 100 percent of children on blockers proceeded to cross-sex hormones, compared to roughly 70 percent who outgrow dysphoria without intervention. Testosterone reduces anxiety but carries risks including cardiovascular disease, vaginal atrophy, and suspected endometrial cancer. Top surgery destroys the capacity for breastfeeding and erotic sensation. Phalloplasty, the surgical construction of a penis from forearm tissue, carries risks including sepsis and disability.
Shrier profiles detransitioners who were once certain they were transgender. Benji identified as a trans man from ages 13 to 19 after discovering trans content online and describes the gender ideology world as a "cult." Her turning point came when a gay friend with leukemia asked why she would choose surgery when she was not dying. Helena, a daughter of Polish immigrants, obtained testosterone from an informed-consent clinic by fabricating childhood dysphoria, then failed to recognize herself in photos and co-founded the Pique Resilience Project. Nearly all detransitioners Shrier interviewed blame the adults who encouraged them.
Shrier interviews Buck Angel, a female-to-male transsexual who credits rigorous gatekeeping with his successful transition. Shrier recommends that parents avoid giving children smartphones, oppose gender ideology in schools, and consider relocating to separate daughters from harmful peer groups. In an afterword, she updates her cases: Lucy quit testosterone after three months; Sally, at 25, uses her given name and female pronouns; Gayatri largely abandoned her trans identity after her parents relocated; Meredith remains on testosterone but gave up her binder. These partial resolutions suggest outcomes remain uncertain.